Use of HIF 1alfa modulators for treatment of cancer

Details for Australian Patent Application No. 2006259352 (hide)

Owner FibroGen, Inc.

Inventors Liu, David Y.; Klauss, Stephen J.; Seeley, Todd A.

Agent FB Rice

Pub. Number AU-A-2006259352

PCT Pub. Number WO2006/138511

Priority 60/691,006 15.06.05 US

Filing date 15 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/63 (2006.01) - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138511 Priority application(s): WO2006/138511

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259353-Bis-aromatic amides and their uses as sweet flavor modifiers, tastants and taste enhancers

2006259349-Benzamide derivatives and uses related thereto